Carbone, Carmine
 Distribuzione geografica
Continente #
EU - Europa 2.685
NA - Nord America 2.213
AS - Asia 1.556
SA - Sud America 213
AF - Africa 35
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.712
Nazione #
US - Stati Uniti d'America 2.166
RU - Federazione Russa 1.001
CN - Cina 575
SG - Singapore 572
GB - Regno Unito 444
IT - Italia 317
DE - Germania 259
BR - Brasile 171
HK - Hong Kong 170
SE - Svezia 158
FI - Finlandia 155
IE - Irlanda 127
VN - Vietnam 123
FR - Francia 107
KR - Corea 31
NL - Olanda 27
CA - Canada 24
UA - Ucraina 23
AR - Argentina 17
ID - Indonesia 17
JP - Giappone 16
MX - Messico 16
BE - Belgio 14
AT - Austria 12
ES - Italia 12
ZA - Sudafrica 12
PL - Polonia 11
TR - Turchia 11
BD - Bangladesh 8
EC - Ecuador 7
IN - India 6
JO - Giordania 6
PY - Paraguay 6
AU - Australia 5
BJ - Benin 5
CO - Colombia 5
MA - Marocco 5
TG - Togo 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EG - Egitto 3
EU - Europa 3
LT - Lituania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
CR - Costa Rica 2
GD - Grenada 2
HN - Honduras 2
IQ - Iraq 2
KE - Kenya 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PE - Perù 2
PK - Pakistan 2
SN - Senegal 2
TW - Taiwan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 6.712
Città #
Southend 389
Chandler 357
Moscow 353
Singapore 273
Dallas 256
Ashburn 231
Hong Kong 162
Woodbridge 152
Dublin 127
Munich 127
Jacksonville 124
Verona 114
Beijing 112
Helsinki 89
Ann Arbor 75
Jinan 53
New York 46
The Dalles 44
Wilmington 40
Lawrence 38
Princeton 38
Houston 37
Redmond 37
Los Angeles 36
Nanjing 34
Shenyang 33
Tianjin 30
Ho Chi Minh City 27
Hanoi 24
Hebei 24
Redondo Beach 22
Turku 21
Dong Ket 20
São Paulo 20
Nanchang 17
Haikou 15
Milan 15
Santa Clara 15
Taiyuan 15
Tokyo 15
Brussels 14
Guangzhou 14
Zhengzhou 14
Jakarta 13
Seattle 13
Sindelfingen 13
Buffalo 12
Columbus 12
London 12
Atlanta 11
Ningbo 11
Boardman 10
Changsha 10
Council Bluffs 10
Frankfurt am Main 10
Montreal 10
Warsaw 10
Bologna 9
Chicago 9
Jiaxing 9
Lappeenranta 9
Redwood City 9
Rio de Janeiro 9
Denver 8
Hangzhou 8
Johannesburg 8
Kent 8
Vienna 8
Brooklyn 7
Mexico City 7
Norwalk 7
Nuremberg 7
Phoenix 7
San Francisco 7
Stockholm 7
Washington 7
Biên Hòa 6
Brasília 6
Jyväskylä 6
Orem 6
Seoul 6
Taizhou 6
Amman 5
Amsterdam 5
Ankara 5
Boston 5
Cotonou 5
Fairfield 5
Falkenstein 5
Isola della Scala 5
Modena 5
Nürnberg 5
Querétaro 5
Asunción 4
Belo Horizonte 4
Cagliari 4
Da Nang 4
Dearborn 4
Falls Church 4
Fuzhou 4
Totale 4.125
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 288
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 274
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 259
Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment 237
Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. 224
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 223
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 206
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 203
A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer 182
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease 182
NF-κB as a target for pancreatic cancer therapy. 179
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 177
An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis 167
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 166
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 164
Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance 163
Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia 162
Anti- VEGF treatment resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype 161
Current Strategies to Overcome Resistance to ALK-Inhibitor Agents 157
Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC 156
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 149
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 148
TGF-beta-activated Kinase 1 (TAK1) is a therapeutic target modulating pancreatic cancer chemoresistance 147
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1. 145
EMT and Treatment Resistance in Pancreatic Cancer 142
Molecular alterations in basal cell carcinoma subtypes 137
Pro-inflammatory factors secreted by pancreatic cancers with evasive resistance to anti-VEGF treatment contribute to malignant progression by inducing EMT 136
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy 135
MEKK3 Sustains EMT and Stemness in Pancreatic Cancer by Regulating YAP and TAZ Transcriptional Activity 130
Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer 124
Toll-Like Receptor 9 Agonists for Cancer Therapy 120
Local ablation disrupts immune evasion in pancreatic cancer 115
Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation 115
Cellular collusion: cracking the code of immunosuppression and chemo resistance in PDAC 111
Pathologic angiogenesis in the bone marrow of humanized sickle cell mice is reversible by blood transfusion 111
TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy 108
PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around 107
Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus 105
MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC 103
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 85
Rationale and clinical use of multitargeting anticancer agents. 83
Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis 71
PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors 69
Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat 64
Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer 63
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story 45
Totale 6.798
Categoria #
all - tutte 22.657
article - articoli 20.770
book - libri 0
conference - conferenze 1.217
curatela - curatele 0
other - altro 670
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021196 0 0 0 0 0 39 7 8 10 55 34 43
2021/2022436 40 150 17 37 11 5 8 24 9 12 19 104
2022/2023820 70 104 75 149 52 200 4 46 96 7 11 6
2023/2024491 13 22 36 54 52 71 27 77 6 35 73 25
2024/20251.292 51 55 51 174 55 78 120 88 213 78 117 212
2025/20262.244 212 161 286 552 876 157 0 0 0 0 0 0
Totale 6.798